Psychedelics as a Treatment for Alzheimer’s Disease Dementia
A Corrigendum on
Psychedelics as a Treatment for Alzheimer's Disease Dementia
by Vann Jones, S. A., and O'Kelly, A. (2020) Front. Synaptic Neurosci. 12:34. doi: 10.3389/fnsyn.2020.00034
In the original article, there was an error. In the “Neurophysiological effects” section, second paragraph, there was an error message in between two of the references: “Error! Bookmark not defined”. All the references are present and correct.
A correction has been made to the “Neurophysiological effects” section, second paragraph. The sentence “Error! Bookmark not defined” has been removed.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: psychedelic, Alzheimer's disease, dementia, plasticicity, microdosing
Citation: Vann Jones SA and O'Kelly A (2020) Corrigendum: Psychedelics as a Treatment for Alzheimer's Disease Dementia. Front. Synaptic Neurosci. 12:607194. doi: 10.3389/fnsyn.2020.607194
Received: 16 September 2020; Accepted: 17 September 2020;
Published: 26 October 2020.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2020 Vann Jones and O'Kelly. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Simon Andrew Vann Jones, s.vannjones@nhs.net